However, in a well-designed, blinded RCT, both intervention and control groups follow the same standardised diabetes management protocols and, consequently, any differences observed in outcomes such as HbA1c, or insulin dose are more likely attributable to the immunomodulatory intervention itself. Here, INS is linked to diabetes mellitus.